Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2024-07-31 Declaration of Voting R…
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING HELD ON 31 JULY 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from the 2024 First Extraordinary General Meeting (EGM) of China Resources Pharmaceutical Group Limited. It details the voting outcome on a specific resolution related to a Supplemental Sales Framework Agreement. The text includes information about the number of shares voted for and against, attendance, and abstentions. It references the Circular and the notice of the EGM but does not contain the full Circular or detailed financial data. The document is essentially reporting the official voting results of a shareholder meeting, which fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5,341 characters, which is consistent with a detailed announcement but not a full report like an Annual Report or Interim Report. Therefore, the correct classification is DVA with high confidence.
2024-07-31 English
CONTINUING CONNECTED TRANSACTIONS PROPERTY LEASING AND PROPERTY MANAGEMENT SERVICES FRAMEWORK AGREEMENT
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a continuing connected transaction involving a Property Leasing and Property Management Services Framework Agreement between the company and its controlling shareholder, CR Holdings. It details the terms, pricing policies, historical amounts, proposed annual caps, internal control measures, reasons and benefits of the transactions, and implications under the Listing Rules. The document is structured as a formal announcement to shareholders and the market about this transaction and its compliance with regulatory requirements. It does not contain financial statements, audit opinions, earnings data, or detailed management discussion of financial results. It is not a report of voting results, nor a call transcript or presentation. The content fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about connected transactions under the Listing Rules, providing required disclosures but not constituting a financial report or other specific filing type. The document length (15,000 characters) and detailed content confirm it is not a brief report publication announcement or a short notice. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-07-23 English
(1) DISCLOSEABLE TRANSACTION PROPOSED ACQUISITION OF GREEN CROSS HK (2) STRATEGIC COOPERATION FRAMEWORK AGREEMENT
M&A Activity Classification · 95% confidence The document is an announcement by a company listed on the Hong Kong Stock Exchange regarding a proposed acquisition of Green Cross HK. It details the terms of the Share Purchase Agreement, consideration, conditions precedent, and strategic cooperation framework agreement. The document references Listing Rules and discloses a discloseable transaction. It is a formal announcement of a corporate transaction rather than a full financial report or earnings release. There is no indication that this is a full merger proxy statement or tender offer filing, but rather a transaction announcement. Therefore, the document fits best under the category of M&A Activity (TAR), which covers announcements and documents related to merger proposals or takeover bids.
2024-07-17 English
ANNOUNCEMENT RESULTS ESTIMATE OF DONG-E-E-JIAO FOR THE SIX MONTHS ENDED 30 JUNE 2024
Earnings Release Classification · 95% confidence The document is an announcement regarding the results estimate of Dong-E-E-Jiao for the six months ended 30 June 2024. It provides estimated financial performance figures such as net profit and earnings per share, but it explicitly states that the results estimate has not been audited or reviewed and that the detailed financial data will be disclosed in the interim report. The document is relatively short (5356 characters) and serves as a preliminary announcement of estimated results rather than a full interim or quarterly report containing actual financial statements and substantive analysis. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. H1 2024
2024-07-12 English
DOCUMENTS ON DISPLAY - CONTINUING CONNECTED TRANSACTIONS
Regulatory Filings Classification · 95% confidence The document is a placeholder message from the Hong Kong Exchanges and Clearing Limited stating that the requested document has been removed by the issuer. Since it does not contain any substantive financial or corporate information and serves as a system-generated notice regarding a missing filing, it falls under the general regulatory announcement category.
2024-07-11 English
Notification of publication of corporate communications on the Company's website
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 12 July 2024 from China Resources Pharmaceutical Group Limited to non-registered holders of securities. It informs recipients that certain corporate communications, including a circular dated 12 July 2024 relating to continuing connected transactions and notice of the 2024 first extraordinary general meeting, are published on the company's website. The letter also includes a request form for printed copies of these communications. The document does not contain substantive financial data or detailed report content but serves as an announcement of the availability of corporate communications and instructions on how to obtain printed copies. It explicitly mentions that corporate communications include annual reports, interim reports, notices of meetings, circulars, and proxy forms, but this document itself is not any of those reports. Given the document length (~6,000 characters) and its content, it fits the definition of a Report Publication Announcement (RPA) rather than the actual reports or other filing types.
2024-07-11 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.